UNIVERSITY OF WASHINGTON
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1861-01-01
- Employees
- 10K
- Market Cap
- -
Analyzing Gene Regions That May Interact With the Effectiveness of High Blood Pressure Drugs
- Conditions
- Death, Sudden, CardiacCerebrovascular AccidentMyocardial Infarction
- First Posted Date
- 2007-12-13
- Last Posted Date
- 2016-11-09
- Lead Sponsor
- University of Washington
- Registration Number
- NCT00573092
- Locations
- 🇺🇸
Cardiovascular Health Research Unit, Seattle, Washington, United States
The Effect of Exercise on Mood After Traumatic Brain Injury
- Conditions
- DepressionTraumatic Brain Injury
- Interventions
- Behavioral: Aerobic exerciseBehavioral: No exercise
- First Posted Date
- 2007-12-12
- Last Posted Date
- 2017-02-06
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 78
- Registration Number
- NCT00571545
- Locations
- 🇺🇸
University of Washington, Seattle, Washington, United States
FDG-Labeled PET Scan in Planning Chemotherapy in Treating Patients With Stage IIIB or IV Non-Small Cell Lung Cancer
- Conditions
- Malignant Pleural EffusionStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
- Interventions
- Drug: carboplatinDrug: docetaxelDrug: gemcitabine hydrochlorideDrug: paclitaxelProcedure: computed tomographyProcedure: positron emission tomographyRadiation: fludeoxyglucose F 18Other: imaging biomarker analysis
- First Posted Date
- 2007-11-28
- Last Posted Date
- 2017-02-10
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 55
- Registration Number
- NCT00564733
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
🇺🇸Harborview Medical Center, Seattle, Washington, United States
Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition Within HIV-1 Discordant Couples
- Conditions
- HIV-1 InfectionsHIV Infections
- Interventions
- Drug: Tenofovir Disoproxil Fumarate (TDF)Drug: Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF)Drug: Placebo
- First Posted Date
- 2007-11-12
- Last Posted Date
- 2019-04-19
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 4758
- Registration Number
- NCT00557245
- Locations
- 🇺🇬
The AIDS Support Organization - Tororo Field Station, Tororo, Uganda
🇺🇬Kabwohe Clinical Research Center, Bushenyi, Uganda
🇰🇪Partners in Prevention - Thika, Thika, Kenya
Randomized Controlled Trial of Vitamin D3 in Diabetic Kidney Disease
- Conditions
- Diabetes MellitusChronic Kidney DiseaseDiabetic Kidney Disease
- Interventions
- Dietary Supplement: CholecalciferolDietary Supplement: Placebo
- First Posted Date
- 2007-11-01
- Last Posted Date
- 2014-04-28
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 22
- Registration Number
- NCT00552409
- Locations
- 🇺🇸
University of Washington, Seattle, Washington, United States
Bacterial Vaginosis; A Randomized Trial to Reduce Recurrence
- Conditions
- Bacterial Vaginosis
- Interventions
- Other: hygienic information plus 62% ethyl alcohol in emollient gelOther: hygienic information
- First Posted Date
- 2007-10-10
- Last Posted Date
- 2007-10-31
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 223
- Registration Number
- NCT00542074
- Locations
- 🇰🇪
Nairobi City Council STI referral clinic (Special Treatment Clinic), Nairobi, Kenya
Hormone and Information Processing Study
- Conditions
- Mild Cognitive ImpairmentAlzheimer's Disease
- Interventions
- Drug: testosterone gelDrug: placebo gel
- First Posted Date
- 2007-10-04
- Last Posted Date
- 2014-07-14
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 22
- Registration Number
- NCT00539305
- Locations
- 🇺🇸
VA Puget Sound Health Care Systems, Seattle, Washington, United States
Automated Real-time Feedback on CPR Study
- Conditions
- Heart Arrest
- Interventions
- Other: Laerdal Q-CPR /technology
- First Posted Date
- 2007-10-04
- Last Posted Date
- 2012-06-25
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 1586
- Registration Number
- NCT00539539
- Locations
- 🇺🇸
University of Pittsburgh, Pittsburgh, Pennsylvania, United States
🇺🇸University of Washington, Seattle, Washington, United States
🇨🇦The Ottawa Hospital, Thunder Bay, Ontario, Canada
HSV-2 Suppression to Reduce Maternal HIV-1 RNA Levels During Pregnancy and Breastfeeding
- First Posted Date
- 2007-09-17
- Last Posted Date
- 2018-12-19
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 148
- Registration Number
- NCT00530777
- Locations
- 🇰🇪
Mathare North City Clinic, Nairobi, Kenya
Trial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIV
- First Posted Date
- 2007-09-11
- Last Posted Date
- 2018-06-07
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 28
- Registration Number
- NCT00527618
- Locations
- 🇺🇸
University of Washington Virology Research Clinic, Seattle, Washington, United States